Dynamics of Serum Tumor Markers Can Serve as a Prognostic Biomarker for Chinese Advanced Non-small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors

Background: Serum tumor markers carcinoembryonic antigen (CEA), cancer antigen 125 (CA125), cytokeratin 19 fragment (CYFRA21-1) and squamous-cell carcinoma-related antigen (SCC-Ag) are routinely used for monitoring the response to chemotherapy or targeted therapy in advanced-stage non-small cell lun...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Zhibo, Yuan, Fang, Chen, Runzhe, Li, Ye, Ma, Junxun, Yan, Xiang, Wang, Lijie, Zhang, Fan, Tao, Haitao, Guo, Dong, Huang, Zhiyue, Zhang, Sujie, Li, Xiaoyan, Zhi, Xiaoyu, Ge, Xiangwei, Hu, Yi, Wang, Jinliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7298878/
https://www.ncbi.nlm.nih.gov/pubmed/32587591
http://dx.doi.org/10.3389/fimmu.2020.01173

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7298878/
https://www.ncbi.nlm.nih.gov/pubmed/32587591
http://dx.doi.org/10.3389/fimmu.2020.01173

Ejemplares similares